Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian Cancer (MITO-5)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute, Naples
ClinicalTrials.gov Identifier:
NCT00401674
First received: November 17, 2006
Last updated: January 13, 2016
Last verified: January 2016